With more than 20 years of patent law experience, Edward DesJardins, PhD*, focuses his practice on patent procurement in the biotechnology arts. He represents clients in a wide range of life sciences and biotechnologies, including CRISPR/Cas genomic editing technologies, cancer therapeutics, disease and viral diagnostics, agricultural crop improvement, stem cell technologies and therapeutic transplantation, viral vector development, and food and beverage processing. His clientele includes multinational corporations, small private biotechnology companies, academics and research institutions. Edward also advises in-house patent counsels, technology transfer managers, business units and laboratory scientists.

Show More


  • US Department of Defense, Breast Cancer Research Program, Gold Standard Distinction
  • Bristol-Meyers Oncology Division Young Investigator Award, American Association of Cancer Research


  • American Intellectual Property Law Association, member
  • San Francisco Intellectual Property Law Association, member
  • Silicon Valley Intellectual Property Law Association, member


University of San Francisco School of Law, JD, 2011
University of Chicago, PhD, Molecular Genetics and Cell Biology, 1996
Bowdoin College, BA, Biochemistry, 1986


Courts / Agencies
US Patent and Trademark Office

Edward DesJardins, PhD

Insights & Events / Media

No results using the selected filter(s)